KalVista Pharmaceuticals Aktie
10,00
EUR
-0,40
EUR
-3,85
%
11,40
USD
+0,18
USD
+1,60
%
Werbung
KalVista Pharmaceuticals Aktie Analyse
20.03.19 | KalVista Pharmaceuticals Buy | Needham & Company, LLC | |
21.09.18 | KalVista Pharmaceuticals Overweight | Cantor Fitzgerald | |
31.08.17 | KalVista Pharmaceuticals Buy | BTIG Research |
Werbung
Werbung